Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis
- PMID: 28740343
- PMCID: PMC5504370
- DOI: 10.3748/wjg.v23.i25.4548
Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis
Abstract
Aim: To characterize the gut bacterial microbiota of patients with primary sclerosing cholangitis (PSC) and ulcerative colitis (UC).
Methods: Stool samples were collected and relevant clinical data obtained from 106 study participants, 43 PSC patients with (n = 32) or without (n = 11) concomitant inflammatory bowel disease, 32 UC patients, and 31 healthy controls. The V3 and V4 regions of the 16S ribosomal RNA gene were sequenced on Illumina MiSeq platform to cover low taxonomic levels. Data were further processed in QIIME employing MaAsLin and LEfSe tools for analysis of the output data.
Results: Microbial profiles in both PSC and UC were characterized by low bacterial diversity and significant change in global microbial composition. Rothia, Enterococcus, Streptococcus, Veillonella, and three other genera were markedly overrepresented in PSC regardless of concomitant inflammatory bowel disease (IBD). Rothia, Veillonella and Streptococcus were tracked to the species level to identify Rothia mucilaginosa, Streptococcus infantus, S. alactolyticus, and S. equi along with Veillonella parvula and V. dispar. PSC was further characterized by decreased abundance of Adlercreutzia equolifaciens and Prevotella copri. Decrease in genus Phascolarctobacterium was linked to presence of colonic inflammation regardless of IBD phenotype. Akkermansia muciniphila, Butyricicoccus pullicaecorum and Clostridium colinum were decreased in UC along with genus Roseburia. Low levels of serum albumin were significantly correlated with enrichment of order Actinomycetales.
Conclusion: PSC is associated with specific gut microbes independently of concomitant IBD and several bacterial taxa clearly distinguish IBD phenotypes (PSC-IBD and UC).
Keywords: Dysbiosis; Gut microbiota; Inflammatory bowel disease; Primary sclerosing cholangitis; Ulcerative colitis.
Conflict of interest statement
Conflict-of-interest statement: The authors declare that there are no competing interests regarding the publication of this paper.
Figures




Similar articles
-
The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.Gut. 2017 Apr;66(4):611-619. doi: 10.1136/gutjnl-2015-310500. Epub 2016 Feb 17. Gut. 2017. PMID: 26887816
-
Characterization of the Gut Microbiota and Mycobiota in Italian Pediatric Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis.Inflamm Bowel Dis. 2024 Apr 3;30(4):529-537. doi: 10.1093/ibd/izad203. Inflamm Bowel Dis. 2024. PMID: 37696680 Free PMC article.
-
Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.Gut. 2016 Oct;65(10):1681-9. doi: 10.1136/gutjnl-2015-311004. Epub 2016 May 20. Gut. 2016. PMID: 27207975 Free PMC article.
-
Gut microbiome in primary sclerosing cholangitis: A review.World J Gastroenterol. 2020 Jun 7;26(21):2768-2780. doi: 10.3748/wjg.v26.i21.2768. World J Gastroenterol. 2020. PMID: 32550753 Free PMC article. Review.
-
Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies.Eur J Gastroenterol Hepatol. 2016 Apr;28(4):383-90. doi: 10.1097/MEG.0000000000000576. Eur J Gastroenterol Hepatol. 2016. PMID: 26938805 Review.
Cited by
-
The Gut-Liver Axis in Cholestatic Liver Diseases.Nutrients. 2021 Mar 21;13(3):1018. doi: 10.3390/nu13031018. Nutrients. 2021. PMID: 33801133 Free PMC article. Review.
-
Alterations of Akkermansia muciniphila in the inflammatory bowel disease patients with washed microbiota transplantation.Appl Microbiol Biotechnol. 2020 Dec;104(23):10203-10215. doi: 10.1007/s00253-020-10948-7. Epub 2020 Oct 16. Appl Microbiol Biotechnol. 2020. PMID: 33064186
-
Assessment of Causal Direction Between Gut Microbiota and Inflammatory Bowel Disease: A Mendelian Randomization Analysis.Front Genet. 2021 Feb 18;12:631061. doi: 10.3389/fgene.2021.631061. eCollection 2021. Front Genet. 2021. PMID: 33679893 Free PMC article.
-
Stratification of human gut microbiomes by succinotype is associated with inflammatory bowel disease status.Microbiome. 2024 Sep 30;12(1):186. doi: 10.1186/s40168-024-01897-8. Microbiome. 2024. PMID: 39350289 Free PMC article.
-
Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy.Front Cell Infect Microbiol. 2023 Jan 10;12:1064537. doi: 10.3389/fcimb.2022.1064537. eCollection 2022. Front Cell Infect Microbiol. 2023. PMID: 36704107 Free PMC article.
References
-
- Gow PJ, Chapman RW. Liver transplantation for primary sclerosing cholangitis. Liver. 2000;20:97–103. - PubMed
-
- Levy C, Lindor KD. Primary sclerosing cholangitis: epidemiology, natural history, and prognosis. Semin Liver Dis. 2006;26:22–30. - PubMed
-
- Karlsen TH, Schrumpf E, Boberg KM. Update on primary sclerosing cholangitis. Dig Liver Dis. 2010;42:390–400. - PubMed
-
- Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660–678. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical